Weill Cornell Breast Center — New York, New York

Weill Cornell Breast Center is a clinical research site located in New York, New York, United States 10065.

Crixeo Clinical Trials Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Weill Cornell Breast Center has participated in 6 clinical trials.

Therapeutic areas: Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Sponsors: Pfizer, Target Health Inc., Polyphor Ltd..

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Weill Cornell Breast Center?

Weill Cornell Breast Center has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Weill Cornell Breast Center conducted?

Weill Cornell Breast Center has 6 clinical trials on record. Their work covers Breast Neoplasms, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation.

Is Weill Cornell Breast Center accredited by Crixeo Clinical Trials?

Weill Cornell Breast Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Weill Cornell Breast Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.